Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Abeona Therapeutics (ABEO) Net Margin (2016 - 2025)

Abeona Therapeutics has reported Net Margin over the past 13 years, most recently at 396.48% for Q4 2025.

  • Quarterly results put Net Margin at 396.48% for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was 1288.95% (changed N/A YoY), and the annual figure for FY2025 was 1152.53%, changed.
  • Net Margin for Q4 2025 was 396.48% at Abeona Therapeutics, down from 28416.75% in the prior quarter.
  • Over the last five years, Net Margin for ABEO hit a ceiling of 97256.25% in Q4 2021 and a floor of 10408.82% in Q4 2022.
  • Median Net Margin over the past 4 years was 308.66% (2021), compared with a mean of 11077.77%.
  • Biggest five-year swings in Net Margin: skyrocketed 9778385bps in 2021 and later tumbled -10766507bps in 2022.
  • Abeona Therapeutics' Net Margin stood at 97256.25% in 2021, then crashed by -111bps to 10408.82% in 2022, then soared by 95bps to 475.83% in 2023, then rose by 17bps to 396.48% in 2025.
  • The last three reported values for Net Margin were 396.48% (Q4 2025), 28416.75% (Q2 2025), and 475.83% (Q2 2023) per Business Quant data.